Cargando…

Can composite digital monitoring biomarkers come of age? A framework for utilization

INTRODUCTION: The application of digital monitoring biomarkers in health, wellness and disease management is reviewed. Harnessing the near limitless capacity of these approaches in the managed healthcare continuum will benefit from a systems-based architecture which presents data quality, quantity,...

Descripción completa

Detalles Bibliográficos
Autores principales: Kovalchick, Christopher, Sirkar, Rhea, Regele, Oliver B., Kourtis, Lampros C., Schiller, Marie, Wolpert, Howard, Alden, Rhett G., Jones, Graham B., Wright, Justin M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5916505/
https://www.ncbi.nlm.nih.gov/pubmed/29707260
http://dx.doi.org/10.1017/cts.2018.4
_version_ 1783317022552096768
author Kovalchick, Christopher
Sirkar, Rhea
Regele, Oliver B.
Kourtis, Lampros C.
Schiller, Marie
Wolpert, Howard
Alden, Rhett G.
Jones, Graham B.
Wright, Justin M.
author_facet Kovalchick, Christopher
Sirkar, Rhea
Regele, Oliver B.
Kourtis, Lampros C.
Schiller, Marie
Wolpert, Howard
Alden, Rhett G.
Jones, Graham B.
Wright, Justin M.
author_sort Kovalchick, Christopher
collection PubMed
description INTRODUCTION: The application of digital monitoring biomarkers in health, wellness and disease management is reviewed. Harnessing the near limitless capacity of these approaches in the managed healthcare continuum will benefit from a systems-based architecture which presents data quality, quantity, and ease of capture within a decision-making dashboard. METHODS: A framework was developed which stratifies key components and advances the concept of contextualized biomarkers. The framework codifies how direct, indirect, composite, and contextualized composite data can drive innovation for the application of digital biomarkers in healthcare. RESULTS: The de novo framework implies consideration of physiological, behavioral, and environmental factors in the context of biomarker capture and analysis. Application in disease and wellness is highlighted, and incorporation in clinical feedback loops and closed-loop systems is illustrated. CONCLUSIONS: The study of contextualized biomarkers has the potential to offer rich and insightful data for clinical decision making. Moreover, advancement of the field will benefit from innovation at the intersection of medicine, engineering, and science. Technological developments in this dynamic field will thus fuel its logical evolution guided by inputs from patients, physicians, healthcare providers, end-payors, actuarists, medical device manufacturers, and drug companies.
format Online
Article
Text
id pubmed-5916505
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-59165052018-04-27 Can composite digital monitoring biomarkers come of age? A framework for utilization Kovalchick, Christopher Sirkar, Rhea Regele, Oliver B. Kourtis, Lampros C. Schiller, Marie Wolpert, Howard Alden, Rhett G. Jones, Graham B. Wright, Justin M. J Clin Transl Sci Research Methods and Technology INTRODUCTION: The application of digital monitoring biomarkers in health, wellness and disease management is reviewed. Harnessing the near limitless capacity of these approaches in the managed healthcare continuum will benefit from a systems-based architecture which presents data quality, quantity, and ease of capture within a decision-making dashboard. METHODS: A framework was developed which stratifies key components and advances the concept of contextualized biomarkers. The framework codifies how direct, indirect, composite, and contextualized composite data can drive innovation for the application of digital biomarkers in healthcare. RESULTS: The de novo framework implies consideration of physiological, behavioral, and environmental factors in the context of biomarker capture and analysis. Application in disease and wellness is highlighted, and incorporation in clinical feedback loops and closed-loop systems is illustrated. CONCLUSIONS: The study of contextualized biomarkers has the potential to offer rich and insightful data for clinical decision making. Moreover, advancement of the field will benefit from innovation at the intersection of medicine, engineering, and science. Technological developments in this dynamic field will thus fuel its logical evolution guided by inputs from patients, physicians, healthcare providers, end-payors, actuarists, medical device manufacturers, and drug companies. Cambridge University Press 2018-04-23 /pmc/articles/PMC5916505/ /pubmed/29707260 http://dx.doi.org/10.1017/cts.2018.4 Text en © The Association for Clinical and Translational Science 2018 http://creativecommons.org/licenses/by/4.0/ This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Methods and Technology
Kovalchick, Christopher
Sirkar, Rhea
Regele, Oliver B.
Kourtis, Lampros C.
Schiller, Marie
Wolpert, Howard
Alden, Rhett G.
Jones, Graham B.
Wright, Justin M.
Can composite digital monitoring biomarkers come of age? A framework for utilization
title Can composite digital monitoring biomarkers come of age? A framework for utilization
title_full Can composite digital monitoring biomarkers come of age? A framework for utilization
title_fullStr Can composite digital monitoring biomarkers come of age? A framework for utilization
title_full_unstemmed Can composite digital monitoring biomarkers come of age? A framework for utilization
title_short Can composite digital monitoring biomarkers come of age? A framework for utilization
title_sort can composite digital monitoring biomarkers come of age? a framework for utilization
topic Research Methods and Technology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5916505/
https://www.ncbi.nlm.nih.gov/pubmed/29707260
http://dx.doi.org/10.1017/cts.2018.4
work_keys_str_mv AT kovalchickchristopher cancompositedigitalmonitoringbiomarkerscomeofageaframeworkforutilization
AT sirkarrhea cancompositedigitalmonitoringbiomarkerscomeofageaframeworkforutilization
AT regeleoliverb cancompositedigitalmonitoringbiomarkerscomeofageaframeworkforutilization
AT kourtislamprosc cancompositedigitalmonitoringbiomarkerscomeofageaframeworkforutilization
AT schillermarie cancompositedigitalmonitoringbiomarkerscomeofageaframeworkforutilization
AT wolperthoward cancompositedigitalmonitoringbiomarkerscomeofageaframeworkforutilization
AT aldenrhettg cancompositedigitalmonitoringbiomarkerscomeofageaframeworkforutilization
AT jonesgrahamb cancompositedigitalmonitoringbiomarkerscomeofageaframeworkforutilization
AT wrightjustinm cancompositedigitalmonitoringbiomarkerscomeofageaframeworkforutilization